COMMUNIQUÉS West-GlobeNewswire

Tauriga Sciences Inc. to Present at European Institutional Investor Conference on June 21, 2018 in Berlin, Germany; Venue is the Representative Office of Baden-Wurttemberg in Berlin

25/04/2018 - 17:01

NEW YORK, NY, April 25, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]

Tauriga Sciences Inc. Board of Directors Approves 1 for 75 Reverse Split, Reducing Its Outstanding Common Stock to Approximately 52,300,000 Shares With a Proportional Reduction of Its Authorized Common Stock to 100,000,000 Shares

25/04/2018 - 16:10

NEW YORK, NY, April 25, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]

Scythian Biosciences Corp. Announces the Appointment of European Cannabis Leader Rob Reid of Prohibition Partners as CEO

25/04/2018 - 15:06

– In addition Scythian announces Liberty Health Sciences CEO George Scorsis as Chairman of the Board and Welcomes Back Rogers Communications Executive Roger Rai to the Board TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- [...]

Progyny and RESOLVE to Ring the Nasdaq Stock Market Closing Bell in Recognition of National Infertility Awareness Week®

25/04/2018 - 15:00

New York City, April 25, 2018 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits management company, and RESOLVE: The National Infertility Association announced today they will ring the Nasdaq Stock Market [...]

Teladoc Announces U.S. Launch of Behavioral Health Navigator

25/04/2018 - 14:35

First Comprehensive Suite of Telebehavioral Health Services Improves Accuracy, Care Coordination and Access, to Drive Improved Outcomes PURCHASE, NY, April 25, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the [...]

Cesca Therapeutics Inc. to Exhibit at Several Upcoming Cell Therapy Conferences

25/04/2018 - 14:30

RANCHO CORDOVA, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ: KOOL ) today announced that the Company will be exhibiting its full suite of cellular processing [...]

Sientra to Showcase OPUS™ Breast Products and miraDry fresh™ Procedure at American Society of Aesthetic Plastic Surgeons Meeting

25/04/2018 - 14:30

Unveils Sientra Platinum20™ Best in Class Warranty Program for OPUS Breast Implants Announces Preliminary Unaudited First Quarter 2018 Net Sales of Approximately $14.5 Million SANTA BARBARA, Calif., April 25, 2018 ( [...]

Profound Medical to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference

25/04/2018 - 14:30

TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]

Ascendis Pharma A/S Announces Upcoming Investor Presentations

25/04/2018 - 14:30

COPENHAGEN, Denmark, April 25, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a clinical stage biopharmaceutical company that applies its innovative TransCon technology to address significant unmet [...]

Alder BioPharmaceuticals® New Data Demonstrated Eptinezumab Increased Migraine-Free Intervals (Up to 32.5 days) and Improved Quality-of-Life Outcomes in Patients with Episodic Migraine

25/04/2018 - 14:30

Patients with a 75% or greater response experienced an eight-fold increase in migraine-free days and more meaningful improvements in bodily pain and physical function BOTHELL, Wash., April 25, 2018 (GLOBE NEWSWIRE) -- [...]

Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

25/04/2018 - 14:18

Reference is made to the annual general meeting of Targovax ASA (the "Company") on 11 April 2018 (the "AGM") where election of members to the board of directors was according to the nomination committee's proposal. At [...]

GTX Corp Sponsor and Presenter at the Safe America World Safe Symposium

25/04/2018 - 14:15

Patrick Bertagna GTX Corp CEO nominated to join the Safe America Board LOS ANGELES, April 25, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO ) , an Internet of Things (IoT) solutions provider in the personal location, [...]

Extendicare Announces Closing of Underwriters' $16.5 Million Over-Allotment Option of 5.00% Convertible Debentures

25/04/2018 - 14:11

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES MARKHAM, Ontario, April 25, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced today that it [...]

Asklepios BioPharmaceutical, Inc. Announces Former Portfolio Company’s Preclinical Asset for Duchenne Muscular Dystrophy Has Advanced into the Clinic

25/04/2018 - 14:05

Pfizer, Inc. Dosed First Patient in its Mini-Dystrophin Gene Therapy Phase 1b Trial Another AskBio Platform Product to be Acquired by Big Pharma Novartis CHAPEL HILL, N.C., April 25, 2018 (GLOBE NEWSWIRE) -- Asklepios [...]

Achaogen to Host Conference Call and Webcast of First Quarter 2018 Financial Results on May 4, 2018

25/04/2018 - 14:01

SOUTH SAN FRANCISCO, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]

AveXis Announces First Patient Dosed in Phase 3 Trial of AVXS-101 in Pre-Symptomatic SMA Types 1, 2 and 3

25/04/2018 - 14:00

CHICAGO, April 25, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, [...]

Rick Van Kirk, CEO of Pro-Dex, Inc. Returns to “Stock Day” with Everett Jolly

25/04/2018 - 14:00

PHOENIX, April 25, 2018 (GLOBE NEWSWIRE) -- Pro-Dex, Inc. (NASDAQ: PDEX ) (“Pro-Dex” the “Company”), CEO Rick Van Kirk joined Everett Jolly on “Stock Day” Podcast. “The Company is close to releasing its first Pro-Dex [...]

Cue Biopharma Announces Appointment of Anish Suri, Ph.D. as Chief Scientific Officer

25/04/2018 - 14:00

Dr. Suri’s appointment to senior leadership team adds depth and expertise in immunology and translational studies CAMBRIDGE, Mass., April 25, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc. (NASDAQ: CUE ), an innovative [...]

Insmed to Host First Quarter 2018 Financial Results Conference Call on Wednesday, May 2, 2018

25/04/2018 - 14:00

BRIDGEWATER, N.J., April 25, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it will [...]